Article
Clinical implications of a novel prognostic factor AIFM3 in breast cancer patients
14 May 2019
Abstract excerpt
BACKGROUND: In a time of increasing concerns over personalized and precision treatment in breast cancer (BC), filtering prognostic factors attracts more attention. Apoptosis-Inducing Factor Mitochondrion-associated 3 (AIFM3) is widely expressed in various tissues and aberrantly expressed in several cancers. However, clinical implication of AIFM3 has not been reported in BC. The aim of the study is to investigate...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
